Skip to main content
. Author manuscript; available in PMC: 2018 Oct 25.
Published in final edited form as: Int J Geriatr Psychiatry. 2015 Mar 11;30(12):1238–1249. doi: 10.1002/gps.4281

Table 2.

Distribution of psychotropic medication class the 914 patients who changed the index antipsychotic medication treatment changed to.

Medication class changed to Olanzapine
Quetiapine
Risperidone
Total
N (%) N (%) N (%) N (%)
Another atypical antipsychotica 30 (28.9) 98 (22.7) 117 (31.0) 245 (26.8)
Conventional antipsychoticb 5 (4.8) 21 (4.9) 16 (4.2) 42 (4.6)
Acetylcholinesterase inhibitorc 14 (13.5) 100 (23.2) 88 (23.3) 202 (22.1)
Antidepressants, not tricyclic antidepressantd 24 (23.1) 70 (16.2) 59 (15.6) 153 (16.7)
Tricyclic antidepressant 0 (0.0) 5 (1.2) 0 (0.0) 5 (0.6)
Memantine 13 (12.5) 63 (14.6) 38 (10.1) 114 (12.5)
Antianxiety medicatione 8 (7.7) 41 (9.5) 35 (9.3) 84 (9.2)
Anticonvulsantf 10 (9.6) 34 (7.9) 25 (6.6) 69 (7.6)
Total 104 432 378 914
a

Includes 40 patients who also added antidepressants, antianxiety, anticholinesterase, anticonvulsant, memantine, conventional antipsychotics, or two atypical antipsychotics.

b

Includes six patients who also added antidepressant, antianxiety, anticonvulsant, or memantine.

c

Includes 16 patients who also added memantine.

d

Includes 12 patients who also added antianxiety, anticholinesterase, anticonvulsant, or memantine.

e

Includes five patients who also added anticholinesterase or anticonvulsant.

f

Includes one patient who also added memeatine.